Viral disease

Related publications (519)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Viral disease

Graph Chatbot

Chat with Graph Search

A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19

KRAB zinc finger protein-mediated control of transposon-embedded regulatory sequences from human germline to early embryos

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model

A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response

Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity

Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study

On the exploration of novel methodological approaches for immunogen design: case studies in influenza and hepatitis C

Therapeutic approaches against coronaviruses acute respiratory syndrome

Sulfonated Nanomaterials with Broad-Spectrum Antiviral Activity Extending beyond Heparan Sulfate-Dependent Viruses